MANHASSET, N.Y.--(BUSINESS WIRE)--Nov 6, 2024-- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that causes painful inflammation throughout the body.
To study the therapeutic potential of non-invasive vagus nerve stimulation (VNS) to curb lupus-related pain and fatigue, Cynthia Aranow, MD, professor in the Institute of Molecular Medicine at The Feinstein Institutes for Medical Research , has been awarded the Lupus Research Alliance (LRA) inaugural Translational Bridge Award for $450,000 over two years. This new project builds upon her previous clinical trial , which showed promising results for using transcutaneous, through the ear, VNS to reduce pain and fatigue in lupus patients. This press release features multimedia.
View the full release here: https://www.businesswire.com/news/home/20241106309271/en/ Dr.
Cynthia Aranow will lead the new lupus focused non-invasive vagus nerve stimulation clinical trial. (Credit: Feinstein Institutes). “Joint and muscle pain, as well as fatigue, are common and debilitating symptoms of systemic lupus erythematosus that significantly affect quality of life,” said Dr.
Aranow. “Our previous research showed that vagus nerve stimulation significantly reduced pain and fatigue associated with lupus, and this new grant from the LRA will allow us to build on our work and move bioelectronic medicine therapy closer to patients who urgently need new treatment options.” The pilot, single-site trial will involve 18 participants.
